Skip to main content
. 2021 Sep 15;12:708636. doi: 10.3389/fphar.2021.708636

TABLE 5.

Comparison of inflammatory biomarkers between the treatment group and control group.

Outcome measure No. of trials Samples Statistical method Effect estimate p-value
WBC count 3 433 MD (fixed) 95%CI 0.38(0.31, 0.44) < 0.00001
LYM count 4 531 MD (random) 95%CI 0.23(0.05, 0.41) 0.01
CRP 4 533 MD (random) 95%CI −12.95(−21.18, −4.01) 0.004